NYXH Nyxoah SA

BEARISH Impact: 7/10 6-K
Horizon immediate Filed Jun 8, 2026 Processed 12d 11h ago SEC 0001104659-26-071359
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
NYXH ▲ +15.67% at T+5d
SHORT call ✗ call lost -15.67% · α vs SPY -13.26% · entry $1.34 → $1.55
Next anchor: T+20d in 16d
Last close $1.60 (close Jun 18) · -19.40% from $1.34 entry (call sign-flipped)
Entry anchored
Jun 8, 03:59 PM ET
via Databento tick
T+1d
-2.24%
call +2.24% · α +0.66%
$1.31
settled 12d ago
T+5d
+15.67%
call -15.67% · α -13.26%
$1.55
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Nyxoah priced a $95M gross underwritten public offering of 55.2M ordinary shares at $1.72/share, representing ~126% dilution from the 43.7M shares outstanding as of March 31, 2026. Net proceeds are expected to be ~$88.5M. The filing also confirms the underwriting agreement and related legal opinions. This massive dilutive capital raise, coming just days after a preliminary prospectus and following a cash runway extending only into Q3 2026, signals acute financial distress and overshadows any positive commercial or regulatory developments.

Actionable Insight

Massive dilution (~126% increase in share count) signals acute financial distress. Monitor for potential further capital needs post-closing and any impact on Nasdaq listing compliance. The offering price of $1.72 is a ~19% premium to the last close of $1.45, but the sheer dilution likely overwhelms any near-term price support. Watch for insider participation details and any subsequent guidance or operational updates.

Key Facts

  • Priced offering of 55,232,558 ordinary shares at $1.72/share, with an underwriter option for up to 8,284,883 additional shares.
  • Gross proceeds of ~$95M; net proceeds of ~$88.5M (€76.3M) after discounts and expenses.
  • Offering represents ~126% dilution relative to 43.7M shares outstanding as of March 31, 2026.
  • Company had only €25.9M in cash and financial assets as of Q1 2026, with cash runway extending only into Q3 2026.
  • Proceeds to fund US commercialization, R&D, and general corporate purposes; company also intends to draw €13.8M from EIB loan in Q2 2026.
  • Insider participation: Chairman Robert Taub, independent directors Jürgen Hambrecht and Kevin Rakin expressed interest to participate, subject to related-party procedure.
  • Offering expected to close June 9, 2026.

Financial Impact

~$88.5M net proceeds from a ~126% dilutive offering; company had €25.9M cash as of Q1 2026 with runway into Q3 2026.

dilutioncashdebt

Risk Factors

  • Extreme dilution (~126%) will pressure the stock price as new shares hit the market.
  • Cash runway only into Q3 2026 suggests additional capital raises may be needed, further diluting holders.
  • Accumulated deficit of €321.7M and ongoing operating losses raise going-concern risk.
  • IPR petitions against competitor Inspire were denied, weakening competitive positioning.
  • CEO transition to a U.S.-based successor adds leadership uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (14 analysts)

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-071359
Document: tm2617103d1_ex5-1.htm0001104659-26-071359
Document: tm2617103d1_ex99-2.htm0001104659-26-071359
Document: tm2617103d1_ex99-1.htm0001104659-26-071359
Document: tm2617103d1_6k.htm0001104659-26-071359
Document: 0001104659-26-071359-index-headers.html0001104659-26-071359
Document: 0001104659-26-071359-index.html0001104659-26-071359
Document: 0001104659-26-071359.txt0001104659-26-071359
9 reports for NYXH
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+20▲ +4.87%Mar 19, 2026
Filters
Rows
Reports for NYXH — sortable, filterable
Type Now
Jun 11, 2026
9d ago
6-K
BEARISH ★ 7/10
$1.39 $1.55▼ −11.51%▼ −9.75%$1.60 (−15.11%)
Jun 8, 2026
12d ago
6-K
BEARISH ★ 7/10
$1.34 $1.31▲ +2.24%▲ +0.66%$1.60 (−19.40%)
Jun 8, 2026
12d ago
424B5
BEARISH ★ 7/10
$1.39 $1.34▲ +3.60%▲ +3.30%$1.60 (−15.11%)
Jun 5, 2026
15d ago
Press Release
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$1.60 (−10.34%)
Jun 4, 2026
16d ago
424B5
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$1.60 (−10.34%)
May 20, 2026
4w ago
Press Release
BULLISH ★ 5/10
$2.87 $2.87· 0.00%▼ −0.45%$1.60 (−44.25%)
May 12, 2026
5w ago
Press Release
MIXED ★ 6/10
$3.08 $3.08· 0.00%▲ +0.00%$1.60 (−48.05%)
Mar 19, 2026
13w ago
Press Release
BULLISH ★ 8/10
$3.08 $3.16▲ +2.60%▲ +1.49%$1.60 (−48.05%)
Mar 5, 2026
15w ago
Press Release
NEUTRAL ★ 3/10
$3.74 $3.49▼ −6.68%▼ −7.53%$1.60 (−57.22%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (29h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access